Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial).

Jolien RobijnsJoy LodewijckxSofie PutsSofie VanmechelenLeen Van BeverStefan ClaesLuc PannekoekeAn TimmermansLeen NoéMieke GoversEvelyn Van de WerfAnnelies MaesPaul BulensJeroen Mebis

Published in: Lasers in surgery and medicine (2021)

Based on the LABRA trial results, PBM seems not able to reduce the incidence of severe ARD in breast cancer patients undergoing HF-WBI. Research in a larger patient population is recommended.

Keyphrases

patients undergoing
phase iii
study protocol
phase ii
clinical trial
liver failure
drug induced
risk factors
early onset
randomized controlled trial
open label
radiation induced
heart failure
radiation therapy
hepatitis b virus
young adults
double blind
extracorporeal membrane oxygenation